In Tanzania, there are 1.4 million people living with HIV (4.7% prevalence). While the country has made incredible strides in addressing the epidemic, adolescent girls and young women continue to be disproportionately affected by and vulnerable to HIV: HIV prevalence triples from age 15-19 to age 20-24 from 1.3% to 4.4%.
Oral pre-exposure prophylaxis (PrEP) is a relatively new biomedical intervention in which antiretroviral medications are taken by an HIV-negative person to prevent acquisition. PrEP has the potential to substantially lower HIV transmission if adolescent girls and young women can access, use and adhere to the medication. But theory, even if backed by evidence, is different when applied in a real-world setting.
In response, a new partnership was formed—including representatives from the Tanzanian government, Population Council, and a Tanzanian research firm—to truly assess barriers and opportunities to introducing PrEP among adolescent girls and young women. A series of briefs summarize formative findings from new Population Council research.
Summary: Introducing oral pre-exposure prophylaxis to adolescent girls and young women in Tanzania: Overview of findings from implementation science research
Results brief 1: Stakeholder considerations for PrEP introduction to adolescent girls and young women: Laying the groundwork for research utilization in Tanzania
Results brief 2: Providers’ views on PrEP for adolescent girls and young women in Tanzania
Results brief 3: Adolescent girls and young women’s perceptions of oral pre-exposure prophylaxis introduction in Tanzania
Results brief 4: Parents’ and guardians’ perceptions of oral pre-exposure prophylaxis for adolescent girls and young women in Tanzania
Results brief 5: Men’s perceptions of oral pre-exposure prophylaxis use by their adolescent and young adult female partners in Tanzania
Results brief 6: Policymakers’ perceptions of oral pre-exposure prophylaxis introduction in Tanzania
Read more about the Population Council’s DREAMS Implementation Science research.
Additional research partners include CSK Research Solutions and the government of Tanzania’s National AIDS Control Programme (NACP) of the Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDEC). This research is supported by the Bill & Melinda Gates Foundation.